Abivax (ABVX) Change in Account Payables (2024 - 2026)

Abivax's Change in Account Payables history runs 3 years deep, the most recent figure standing at -$9.4 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 170.23% year-over-year to -$9.4 million; the TTM figure through Mar 2026 stood at -$31.7 million (down 820.02% YoY), while the FY2025 annual figure was -$7.2 million, down 96.42% from the prior year.
• Change in Account Payables was -$9.4 million for Q1 2026 at Abivax, down from $9.4 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $15.0 million in Q3 2024 to a low of -$32.7 million in Q3 2025.
• Historically, Change in Account Payables has averaged -$2.4 million across 3 years, with a median of $1.1 million in 2025.
• Biggest YoY gain for Change in Account Payables was 5088.78% in 2025; the steepest drop was 318.09% in 2025.
• A 3-year view of Change in Account Payables shows it stood at $180592.6 in 2024, then surged by 5088.78% to $9.4 million in 2025, then slumped by 200.55% to -$9.4 million in 2026.
• The last three Change in Account Payables figures came in at -$9.4 million (Q1 2026), $9.4 million (Q4 2025), and -$32.7 million (Q3 2025), per Business Quant data.